File(s) not publicly available
When the cure kills—CBD limits biodiversity research
journal contributionposted on 11.11.2021, 03:26 by K Divakaran Prathapan, R Pethiyagoda, KS Bawa, PH Raven, PD Rajan, LE Acosta, B Adams, ML Bean Museum, S Adl, R Anderson, ABT Smith, CP Arango, MA Arnedo, JW Armbruster, LJ Avila, CO Azevedo, D Baldo, MVL Barclay, DJ Gower, LE Hughes, R Baron-Szabo, AM Bauer, B Bentlage, A Bezděk, G Bird, V Blagoderov, L Bocak, A Bonaldo, JE Bond, CJ Borkent, MA Branham, S Carranza, R Carreno, MR de Carvalho, S Castroviejo-Fisher, H Chiba, F Čiampor, DJ Clarke, AG Collins, R Constantino, FA Crespo, M Daly, P Dominiak, N Dronen, A Dubois, TF Duda, M Eléaume, S Erlacher, P Cordeiro Estrela, N Evenhuis, K Hoch Fehlauer-Ale, H Fery, U Fritz, SD Gaimari, R Garrison, PH Kerr, P Gaubert, DL Geiger, AC Gill, ML Gimmel, T Goldschmidt, R Goswami, A Pérez González, VH Gonzalez, D Gordon, P Greenslade, VI Gusarov, E Hajdu, D Harms, MP Heinicke, EJ Hilton, CJ Hodgson, G Hormiga, P Hutchings, P Jäger, JT Jennings, M Kadej, L Kaila, MJ Kamiński, A Stroiński, GS Karaman, T Karanovic, J Kathirithamby, LR Kirkendall, MV Kitahara, M Klautau, BC Kondratieff, A Kroh, FM Labarque, JM Leavengood, A Letardi, AP Liang, FCT Lima, Z Liu, I Löbl, V Lohrmann, N Malchus, Mallik MalipatilMallik Malipatil
The Convention on Biological Diversity (CBD) commits its 196 nation parties to conserve biological diversity, use its components sustainably, and share fairly and equitably the benefits from the utilization of genetic resources. Although these aspirations are laudable, the 2014 Nagoya Protocol and resulting national ambitions on Access and Benefit Sharing (ABS) of genetic resources have generated unintended consequences.